 |
|
|
|
CMA241a
Human tumor cell array, 12 cell lines/24 cores, replacing CMA241
|
|
| Microarray Panel: | Human tumor cell microarray, containing 12 tumor cell lines (one each of SW480, HT-29, Hep G2, HHCC, AGS, SK-BR-3, DU145, A-375, A549, SPC-A-1, SHG-44, MCF-7), duplicate cores per cell line |
| Cores: | 24 |
|
| Cases: | 12 |
| Layout: | 6 cols × 4 rows |
| Core Diameter: | 2 mm |
| Thickness: | 3 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bra - Brain,
Bre - Breast,
Col - Colon,
Liv - Liver,
Lun - Lung,
Pro - Prostate,
Sto - Stomach,
Ute - Uterine cervix
 - Malignant tumor
|
Specification Sheet
| Pos |
No. |
Organ |
Pathology diagnosis |
Notes |
Type † |
|
A1 |
1 |
Colon |
Colorectal adenocarcinoma (SW480) |
Adherent growth, epithelia |
Malignant |
|
A2 |
2 |
Colon |
Colorectal adenocarcinoma (SW480) |
Adherent growth, epithelia |
Malignant |
|
A3 |
3 |
Colon |
Colorectal adenocarcinoma (HT-29) |
Adherent growth, epithelia |
Malignant |
|
A4 |
4 |
Colon |
Colorectal adenocarcinoma (HT-29) |
Adherent growth, epithelia |
Malignant |
|
A5 |
5 |
Liver |
Hepatocellular carcinoma (Hep G2) |
Adherent growth, epithelia |
Malignant |
|
A6 |
6 |
Liver |
Hepatocellular carcinoma (Hep G2) |
Adherent growth, epithelia |
Malignant |
|
B1 |
7 |
Liver |
Liver carcinoma (HHCC) |
Adherent growth, epithelia |
Malignant |
|
B2 |
8 |
Liver |
Liver carcinoma (HHCC) |
Adherent growth, epithelia |
Malignant |
|
B3 |
9 |
Stomach |
Gastric adenocarcinoma (AGS) |
Adherent growth, epithelia |
Malignant |
|
B4 |
10 |
Stomach |
Gastric adenocarcinoma (AGS) |
Adherent growth, epithelia |
Malignant |
|
B5 |
11 |
Brain |
Glioma (SHG-44) |
Adherent growth, epithelia |
Malignant |
|
B6 |
12 |
Brain |
Glioma (SHG-44) |
Adherent growth, epithelia |
Malignant |
|
C1 |
13 |
Prostate |
Carcinoma, derived from metastatic site: brain (DU 145) |
Adherent growth, epithelia |
Malignant |
|
C2 |
14 |
Prostate |
Carcinoma, derived from metastatic site: brain (DU 145) |
Adherent growth, epithelia |
Malignant |
|
C3 |
15 |
Uterine cervix |
Carcinoma (Caski) |
Adherent growth, epithelia |
Malignant |
|
C4 |
16 |
Uterine cervix |
Carcinoma (Caski) |
Adherent growth, epithelia |
Malignant |
|
C5 |
17 |
Lung |
Carcinoma (A549) |
Adherent growth, epithelia |
Malignant |
|
C6 |
18 |
Lung |
Carcinoma (A549) |
Adherent growth, epithelia |
Malignant |
|
D1 |
19 |
Lung |
Carcinoma (SPC-A-1) |
Adherent growth, epithelia |
Malignant |
|
D2 |
20 |
Lung |
Carcinoma (SPC-A-1) |
Adherent growth, epithelia |
Malignant |
|
D3 |
21 |
Breast |
Adenocarcinoma (SK-BR-3) |
Adherent growth, epithelia |
Malignant |
|
D4 |
22 |
Breast |
Adenocarcinoma (SK-BR-4) |
Adherent growth, epithelia |
Malignant |
|
D5 |
23 |
Breast |
Adenocarcinoma (MCF-7) |
Adherent growth, epithelia |
Malignant |
|
D6 |
24 |
Breast |
Adenocarcinoma (MCF-7) |
Adherent growth, epithelia |
Malignant |
"-" No grading available, *Tissue dots may be missing or histologically unidentifiable.
† For precise diagnosis, refer to pathology description.
|
|
